Göpel, Sven O.
Adingupu, Damilola
Wang, Jue
Semenova, Elizaveta
Behrendt, Margareta
Jansson-Löfmark, Rasmus
Ahlström, Christine
Jönsson-Rylander, Ann-Cathrine
Gopaul, V. Sashi
Esterline, Russell
Gan, Li-Ming
Xiao, Rui-Ping
Funding for this research was provided by:
AstraZeneca
Article History
Received: 30 July 2024
Accepted: 24 October 2024
First Online: 15 November 2024
Declarations
:
: Mouse study: Animal care and experiments comply to the Swedish national regulations L150 for the protection of animals used for scientific purposes. The project protocol was assessed and approved by the Gothenburg Regional Animal Ethics Committee for Animal Experimental permit no 86 2015. NHP study: The present PK and efficacy studies were approved by the Institutional Animal Care and Use Committee of Peking University. The housing and experimental procedures were in accordance with the principles of laboratory animal care of the National Academy of Sciences/National Research Council.
: Not applicable.
: The authors declare no competing interests.